[
  {
    "ts": null,
    "headline": "Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer",
    "summary": "Compared to ABBV, PFE's latest dividend declarations and earnings report reveal growth pressure, high payout ratios, and inventory buildup. Read the full analysis now.",
    "url": "https://finnhub.io/api/news?id=aee37e1c4747b96e5f5174d69ffbc8d59b02f1b22913d1a986cce509f9a8169e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762583923,
      "headline": "Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer",
      "id": 137377931,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2161348037/image_2161348037.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Compared to ABBV, PFE's latest dividend declarations and earnings report reveal growth pressure, high payout ratios, and inventory buildup. Read the full analysis now.",
      "url": "https://finnhub.io/api/news?id=aee37e1c4747b96e5f5174d69ffbc8d59b02f1b22913d1a986cce509f9a8169e"
    }
  },
  {
    "ts": null,
    "headline": "Piper Sandler Raises AbbVie (ABBV) Price Target to $289, Maintains Overweight Rating",
    "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 15 Best DRIP Stocks to Own Right Now. On November 5, Piper San‍dler​ analyst David Amsellem raised the price target on AbbVie Inc. (NYSE:ABBV) from⁠ $284 to $289 while maintaining an Over‌weight rating on the stock foll‌owing its quarte‍rly re​sults, as reported by The Fly. The analyst att‍ributed […]",
    "url": "https://finnhub.io/api/news?id=fd8bce0d6daa53af26ee2c77113336ace28015c4851137b08ce84cf5115305e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762580183,
      "headline": "Piper Sandler Raises AbbVie (ABBV) Price Target to $289, Maintains Overweight Rating",
      "id": 137378348,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 15 Best DRIP Stocks to Own Right Now. On November 5, Piper San‍dler​ analyst David Amsellem raised the price target on AbbVie Inc. (NYSE:ABBV) from⁠ $284 to $289 while maintaining an Over‌weight rating on the stock foll‌owing its quarte‍rly re​sults, as reported by The Fly. The analyst att‍ributed […]",
      "url": "https://finnhub.io/api/news?id=fd8bce0d6daa53af26ee2c77113336ace28015c4851137b08ce84cf5115305e5"
    }
  }
]